Oregon Public Employees Retirement Fund’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,452
| Closed | -$97.9K | – | 1713 |
|
|
2023
Q1 | $97.9K | Sell |
3,452
-10
| -0.3% | -$284 | ﹤0.01% | 1671 |
|
|
2022
Q4 | $101K | Sell |
3,462
-213
| -6% | -$6.23K | ﹤0.01% | 1670 |
|
|
2022
Q3 | $97K | Sell |
3,675
-167
| -4% | -$4.41K | ﹤0.01% | 1658 |
|
|
2022
Q2 | $171K | Sell |
3,842
-500
| -12% | -$22.3K | ﹤0.01% | 1443 |
|
|
2022
Q1 | $215K | Sell |
4,342
-100
| -2% | -$4.95K | ﹤0.01% | 1612 |
|
|
2021
Q4 | $226K | Sell |
4,442
-441
| -9% | -$22.4K | ﹤0.01% | 1503 |
|
|
2021
Q3 | $272K | Hold |
4,883
| – | – | ﹤0.01% | 1471 |
|
|
2021
Q2 | $209K | Hold |
4,883
| – | – | ﹤0.01% | 1517 |
|
|
2021
Q1 | $204K | Buy |
4,883
+100
| +2% | +$4.18K | ﹤0.01% | 1530 |
|
|
2020
Q4 | $223K | Buy |
4,783
+724
| +18% | +$33.8K | ﹤0.01% | 1477 |
|
|
2020
Q3 | $172K | Hold |
4,059
| – | – | ﹤0.01% | 1448 |
|
|
2020
Q2 | $195K | Hold |
4,059
| – | – | ﹤0.01% | 1404 |
|
|
2020
Q1 | $187K | Hold |
4,059
| – | – | ﹤0.01% | 1356 |
|
|
2019
Q4 | $244K | Sell |
4,059
-200
| -5% | -$12K | ﹤0.01% | 1427 |
|
|
2019
Q3 | $241K | Buy |
4,259
+100
| +2% | +$5.66K | ﹤0.01% | 1485 |
|
|
2019
Q2 | $232K | Sell |
4,159
-100
| -2% | -$5.58K | ﹤0.01% | 1506 |
|
|
2019
Q1 | $215K | Buy |
4,259
+77
| +2% | +$3.89K | ﹤0.01% | 1504 |
|
|
2018
Q4 | $168K | Buy |
+4,182
| New | +$168K | ﹤0.01% | 1546 |
|